NCT06125002View on ClinicalTrials.gov

Diosmin for Treatment of Delayed-onset Muscle Soreness (DOMS)

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

March 31, 2024

Study Completion Date

May 31, 2024

Conditions
Myalgia
Interventions
DRUG

Diosmin750

The ingestion will occur orally, under monitoring by the responsible investigator.

DRUG

Placebo

The ingestion will occur orally, under monitoring by the responsible investigator.

Trial Locations (1)

86057-970

RECRUITING

Universidade Estadual de Londrina, Londrina

All Listed Sponsors
collaborator

Universidade Norte do Paraná

OTHER

lead

Sergio Marques Borghi

OTHER